• Despite relatively high prevalence of psoriasis at 0.4 to 2.8 % in the Indian population and availability of many treatment options, India is behind in psoriasis disease management¹.
• Research done on specific ethnic backgrounds and data from one population is not a global solution. Hence it has been recommended by WHO’s global report on Psoriasis, that Psoriasis research should focus on specific ethnicity and therapeutics that are unique to a specific population ².
• There is an increasing demand for crucial studies addressing definitive curative therapies.

Hence, well-conducted research specific to Indian population considering the differences in genetic makeup, environmental influences and health care costs could go a long way in improving the healthcare services for the psoriasis patients ³.

1. Thappa DM, Munisamy M. Research on psoriasis in India: Where do we stand? Indian J Med Res. 2017;146(2):147-149. doi: 10.4103/ijmr.IJMR_1296_17

2. https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf.psoriasis;jsessionid=54912784D28C9F36ECCD45471AC5775B?sequence=1
3. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016; 7:471–80